With box warnings

Without box warnings

Branded

Generic

2 results

bavencio
(avelumab)
EMD Serono, Inc.
Usage: BAVENCIO (avelumab) is indicated for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma, maintenance treatment of locally advanced or metastatic urothelial carcinoma after platinum chemotherapy, and first-line treatment of advanced renal cell carcinoma in combination with axitinib.
imfinzi
(Durvalumab)
AstraZeneca Pharmaceuticals LP
Usage: IMFINZI is indicated for various cancers, including resectable non-small cell lung cancer (NSCLC), unresectable Stage III NSCLC, small cell lung cancer (SCLC), biliary tract cancer, hepatocellular carcinoma, advanced or recurrent endometrial cancer, and muscle invasive bladder cancer in combination with other treatments.

Programmed Death Ligand-1 Blocker class drugs

bavencio